Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

AMERISAFE (NASDAQ:AMSF) Stock Price Target Cut by Citizens Jmp

AMERISAFE logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Citizens JMP cut AMERISAFE’s price target from $40 to $35 while maintaining a “market outperform” rating, implying roughly 53.7% upside from the $22.77 share price.
  • Analyst sentiment is mixed: AMERISAFE has an average “Hold” rating and a consensus price target of $34, with two Buy, two Hold, and one Sell rating.
  • Shares fell to $22.77 after the company reported quarterly EPS of $0.40, below the $0.48 consensus estimate, while revenue of $76.67 million also missed expectations.
  • Five stocks we like better than AMERISAFE.

AMERISAFE (NASDAQ:AMSF - Get Free Report) had its target price reduced by analysts at Citizens Jmp from $40.00 to $35.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a "market outperform" rating on the insurance provider's stock. Citizens Jmp's price target points to a potential upside of 53.74% from the stock's current price.

AMSF has been the topic of a number of other research reports. Zacks Research upgraded AMERISAFE from a "strong sell" rating to a "hold" rating in a research note on Monday, September 28th. Citigroup reissued a "market outperform" rating on shares of AMERISAFE in a report on Monday, October 12th. Truist Financial decreased their price target on AMERISAFE from $32.00 to $27.00 and set a "hold" rating on the stock in a research report on Tuesday, October 13th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of AMERISAFE in a research note on Monday. Finally, Morgan Stanley set a $40.00 price objective on shares of AMERISAFE in a research report on Monday, October 12th. Two investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, AMERISAFE has an average rating of "Hold" and a consensus price target of $34.00.

View Our Latest Stock Analysis on AMSF

AMERISAFE Stock Performance

Shares of AMSF stock traded down $2.54 on Thursday, hitting $22.77. The company's stock had a trading volume of 97,749 shares, compared to its average volume of 290,113. AMERISAFE has a fifty-two week low of $22.73 and a fifty-two week high of $42.10. The company has a market capitalization of $422.06 million, a PE ratio of 9.21 and a beta of 0.24. The stock's 50 day moving average is $25.06 and its 200-day moving average is $31.14.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The insurance provider reported $0.40 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.48 by ($0.08). AMERISAFE had a net margin of 14.00% and a return on equity of 14.87%. The business had revenue of $76.67 million during the quarter, compared to the consensus estimate of $84.72 million. On average, research analysts forecast that AMERISAFE will post 1.95 earnings per share for the current year.

Hedge Funds Weigh In On AMERISAFE

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new stake in AMERISAFE in the second quarter valued at approximately $122,167,000. Bank of America Corp DE purchased a new position in shares of AMERISAFE in the 2nd quarter worth approximately $18,755,000. Bank of New York Mellon Corp bought a new stake in shares of AMERISAFE during the 2nd quarter worth $3,583,000. Palisade Capital Management LP purchased a new stake in AMERISAFE during the second quarter worth about $3,145,000. Finally, Sei Investments Co. raised its position in AMERISAFE by 125.0% in the first quarter. Sei Investments Co. now owns 138,584 shares of the insurance provider's stock worth $4,619,000 after acquiring an additional 76,989 shares during the period. 97.41% of the stock is currently owned by institutional investors and hedge funds.

About AMERISAFE

(Get Free Report)

AMERISAFE, Inc is a specialty workers' compensation insurance company serving small and midsized businesses. The company focuses on employers in industries with elevated workplace risks, including construction, trucking, logging, agriculture, manufacturing, and maritime operations.

Through its insurance subsidiaries, AMERISAFE provides workers' compensation coverage designed to protect businesses from costs associated with workplace injuries and occupational illnesses. Its services also include workplace safety and loss-control support, claims management, medical cost containment, and premium audit services.

Headquartered in DeRidder, Louisiana, AMERISAFE primarily serves employers in the southeastern and south-central United States.

Featured Stories

Analyst Recommendations for AMERISAFE (NASDAQ:AMSF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in AMERISAFE Right Now?

Before you consider AMERISAFE, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.

While AMERISAFE currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines